A combinatorial approach to biophysically characterise chemokine-glycan binding affinities for drug development. [electronic resource]
- Molecules (Basel, Switzerland) Jul 2014
- 10618-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1420-3049
10.3390/molecules190710618 doi
Animals Anti-Inflammatory Agents--pharmacology Cell Line Drug Design Glycosaminoglycans--genetics Humans Inflammation--drug therapy Interleukin-8--genetics Protein Binding Protein Engineering Receptors, CXCR--metabolism